Akiyasu Kouketsu

507 total citations
8 papers, 439 citations indexed

About

Akiyasu Kouketsu is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Akiyasu Kouketsu has authored 8 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Akiyasu Kouketsu's work include Histone Deacetylase Inhibitors Research (7 papers), Protein Degradation and Inhibitors (6 papers) and Peptidase Inhibition and Analysis (4 papers). Akiyasu Kouketsu is often cited by papers focused on Histone Deacetylase Inhibitors Research (7 papers), Protein Degradation and Inhibitors (6 papers) and Peptidase Inhibition and Analysis (4 papers). Akiyasu Kouketsu collaborates with scholars based in Japan. Akiyasu Kouketsu's co-authors include Naoki Miyata, Takayoshi Suzuki, Hidehiko Nakagawa, Minoru Yoshida, Satoko Maeda, Yukihiro Itoh, Sakiko Maruyama, Arihiro Kohara, Kohfuku Kohda and Shinichi Ninomiya and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Synthesis.

In The Last Decade

Akiyasu Kouketsu

8 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akiyasu Kouketsu Japan 7 397 169 169 41 25 8 439
Johanna Senger Germany 12 396 1.0× 199 1.2× 178 1.1× 53 1.3× 7 0.3× 16 512
Patrick M. Lombardi United States 8 473 1.2× 63 0.4× 131 0.8× 58 1.4× 12 0.5× 10 526
Jérôme Cluzeau Canada 11 276 0.7× 155 0.9× 71 0.4× 17 0.4× 9 0.4× 19 400
Alan F. Haughan United Kingdom 12 210 0.5× 187 1.1× 32 0.2× 60 1.5× 23 0.9× 19 347
J.D. Osko United States 10 403 1.0× 122 0.7× 243 1.4× 31 0.8× 8 0.3× 13 429
R. Tahilramani Poland 12 250 0.6× 166 1.0× 73 0.4× 14 0.3× 8 0.3× 17 440
Daniel Herp Germany 11 498 1.3× 115 0.7× 216 1.3× 26 0.6× 3 0.1× 13 574
Dahvid Davda United States 7 292 0.7× 41 0.2× 85 0.5× 10 0.2× 7 0.3× 7 382
Lewis E. Pennicott United Kingdom 7 319 0.8× 48 0.3× 222 1.3× 21 0.5× 3 0.1× 13 399
Brian Eastman United States 5 133 0.3× 110 0.7× 106 0.6× 8 0.2× 12 0.5× 12 253

Countries citing papers authored by Akiyasu Kouketsu

Since Specialization
Citations

This map shows the geographic impact of Akiyasu Kouketsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiyasu Kouketsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiyasu Kouketsu more than expected).

Fields of papers citing papers by Akiyasu Kouketsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiyasu Kouketsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiyasu Kouketsu. The network helps show where Akiyasu Kouketsu may publish in the future.

Co-authorship network of co-authors of Akiyasu Kouketsu

This figure shows the co-authorship network connecting the top 25 collaborators of Akiyasu Kouketsu. A scholar is included among the top collaborators of Akiyasu Kouketsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiyasu Kouketsu. Akiyasu Kouketsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Shibuya, Kimiyuki, et al.. (2012). A Practical Synthesis of (S)-tert-Butyl 3-Methyl-1,4-diazepane-1-carboxylate, the Key Intermediate of Rho–Kinase Inhibitor K-115. Synthesis. 44(20). 3171–3178. 7 indexed citations
2.
Itoh, Yukihiro, Takayoshi Suzuki, Akiyasu Kouketsu, et al.. (2007). Design, Synthesis, Structure−Selectivity Relationship, and Effect on Human Cancer Cells of a Novel Series of Histone Deacetylase 6-Selective Inhibitors. Journal of Medicinal Chemistry. 50(22). 5425–5438. 87 indexed citations
3.
Suzuki, Takayoshi, Akiyasu Kouketsu, Yukihiro Itoh, et al.. (2006). Highly Potent and Selective Histone Deacetylase 6 Inhibitors Designed Based on a Small-Molecular Substrate. Journal of Medicinal Chemistry. 49(16). 4809–4812. 91 indexed citations
4.
Suzuki, Takayoshi, et al.. (2005). Design and synthesis of non-hydroxamate histone deacetylase inhibitors: identification of a selective histone acetylating agent. Bioorganic & Medicinal Chemistry. 13(13). 4332–4342. 20 indexed citations
5.
Suzuki, Takayoshi, Yuki Nagano, Akiyasu Kouketsu, et al.. (2005). Novel Inhibitors of Human Histone Deacetylases:  Design, Synthesis, Enzyme Inhibition, and Cancer Cell Growth Inhibition of SAHA-Based Non-hydroxamates. Journal of Medicinal Chemistry. 48(4). 1019–1032. 99 indexed citations
6.
Suzuki, Takayoshi, Akiyasu Kouketsu, Arihiro Kohara, et al.. (2004). Thiol-based SAHA analogues as potent histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(12). 3313–3317. 81 indexed citations
7.
Suzuki, Takayoshi, et al.. (2004). Identification of a potent non-hydroxamate histone deacetylase inhibitor by mechanism-based drug design. Bioorganic & Medicinal Chemistry Letters. 15(2). 331–335. 53 indexed citations
8.
Suzuki, Takayoshi, Akiyasu Kouketsu, Arihiro Kohara, et al.. (2004). Thiol‐Based SAHA Analogues as Potent Histone Deacetylase Inhibitors.. ChemInform. 35(42). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026